In focus · trending topic

homozygous familial hyperchole

2 stories · following the connections

Novelion Therapeutics’ Subsidiary Launches JUXTAPID® (lomitapide) in Japan

By Nasdaq OMXDec 16, 2016, 1:36 PM UTC

CymaBay Therapeutics Announces Positive Results from its Pilot Phase 2 Clinical Study of MBX-8025 in Patients with Homozygous Familial Hypercholesterolemia

By Nasdaq OMXMar 17, 2016, 8:01 PM UTC